These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3299496)

  • 1. Efficacy of oral hydergine (ergoloid mesylates) in alcohol related encephalopathy.
    Datta KD; Evenson RC; Gannon PJ; Dick EP
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):87-90. PubMed ID: 3299496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
    van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
    J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergoloid mesylates ('Hydergine') in the treatment of mental deterioration in the elderly: a 6-month double-blind, placebo-controlled trial.
    Rouy JM; Douillon AM; Compan B; Wolmark Y
    Curr Med Res Opin; 1989; 11(6):380-9. PubMed ID: 2651014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of efficacy of hydergine in patients with Alzheimer's disease.
    Thompson TL; Filley CM; Mitchell WD; Culig KM; LoVerde M; Byyny RL
    N Engl J Med; 1990 Aug; 323(7):445-8. PubMed ID: 2082953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
    Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study of 93 cases of painful shoulder and shoulder-band syndrome treated with hydergine (author's transl)].
    Yaya Huamán R; Blasco Olcina R; García Fernández M; Vilches Padilla JJ
    Rev Esp Otoneurooftalmol Neurocir; 1975; 33(193):131-5. PubMed ID: 56021
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of long-term ergoloid mesylates ('Hydergine') administration in healthy pensioners: 5-year results.
    Huber F; Köberle S; Prestele H; Spiegel R
    Curr Med Res Opin; 1986; 10(4):256-79. PubMed ID: 3780290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Letter: Double blind study of hydergine in aged patients].
    Paux G; Boismare F; Delaunay P
    Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
    [No Abstract]   [Full Text] [Related]  

  • 9. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
    Hughes JR; Williams JG; Currier RD
    J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
    Thibault A
    Curr Med Res Opin; 1974; 2(8):482-7. PubMed ID: 4217240
    [No Abstract]   [Full Text] [Related]  

  • 11. Ergoloid mesylates for senile dementias: unanswered questions.
    Hollister LE; Yesavage J
    Ann Intern Med; 1984 Jun; 100(6):894-8. PubMed ID: 6372566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relieving select symptoms of the elderly.
    Nelson JJ
    Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of drepanocytic painful crises with hydergine].
    Cuisinier JC; Ducloux M; Lagarde B; Barbotin M; Darracq R
    Bull Soc Med Afr Noire Lang Fr; 1974; 19(2):168-72. PubMed ID: 4219596
    [No Abstract]   [Full Text] [Related]  

  • 14. Ergoloid mesylates and ECT.
    Sachs GS; Gelenberg AJ; Bellinghausen B; Wojcik J; Falk WE; Farhadi AM; Jenike M
    J Clin Psychiatry; 1989 Mar; 50(3):87-90. PubMed ID: 2647711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helping to make the final years meaningful for the elderly residents of nursing homes.
    Einspruch BC
    Dis Nerv Syst; 1976 Aug; 37(8):439-42. PubMed ID: 821734
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic management of the symptoms of dementia.
    McDonald WM; Krishnan KR
    Am Fam Physician; 1990 Jul; 42(1):123-32. PubMed ID: 2195854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
    Matejcek M; Knor K; Piguet PV; Weil C
    J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ergoloid mesylates vs. Alzheimer's: the latest round.
    Walker C
    Geriatrics; 1990 Dec; 45(12):22, 24. PubMed ID: 2253892
    [No Abstract]   [Full Text] [Related]  

  • 20. Sinus bradycardia following treatment with hydergine for cerebrovascular insufficiency.
    Dcayley AC; Macpherson A; Wedgwood J
    Br Med J; 1975 Nov; 4(5993):384-5. PubMed ID: 811310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.